Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (2758)	11/13/1997 5:21:00 PM
From: JOHN W.	Read Replies (2) \| Respond to of 6136

<Picture><Picture> Money for ADAP Increases significantly. Congress Completes Labor/HHS Appropriations Bill -- Finally! AIDS Action Network Alert November 11, 1997 The conference committee for the Labor, Health and Human Services and Education (Labor/HHS) FY 98 appropriations bill completed its work on the bill Friday, November 7, and its report was passed overwhelmingly by both the House and Senate. It appears likely that President Clinton will sign the bill when it reaches his desk. Syringe Exchange: As reported in our last alert, the bill contains new language on restricting federal funding for syringe exchange programs. The bill does allow the secretary of health and human services to retain the authority to lift the funding ban if she determines that syringe exchange programs prevent the spread of HIV and do not encourage the use of illegal drugs. However, there is a moratorium (through March 31, 1998) on her ability to exercise this authority. In addition, the bill requires that a federally funded syringe exchange program be "operated in accordance with criteria established by the Secretary for preventing the spread of HIV and for ensuring that the project does not encourage the use of illegal drugs." The conference report for the bill recommends the following criteria: 1."a program for preventing HIV transmission is operating in the community," 2.the State or local health officer has determined that an exchange project is likely to be an effective component of such a prevention program," 3.the exchange project provides referrals for treatment of drug abuse and for other appropriate health and social services," 4.such project provides information on reducing the risk of transmission of HIV," 5."the project complies with established standards for the disposal of hazardous medical waste," and 6."the State or local health officer agrees that, as needs are identified by the Secretary, the officer will collaborate with federally supported programs of research and evaluation that relate to exchange projects." AIDS Action will be encouraging the secretary to make a determination regarding this issue immediately and to lift the funding ban as soon as the moratorium is over. Meanwhile, we will continue to assist in laying the groundwork necessary for her to do so. An upcoming AIDS Action Network Alert will provide more details about this process and actions our Network members may take to support this initiative. Funding for Federal HIV/AIDS Programs: Now that the Labor/HHS appropriations bill has been completed by Congress, funding levels for all federal HIV/AIDS programs are now set for FY 98. Included in this Network Alert is an updated chart of FY 98 appropriations for these programs. AIDS Action: Please take a moment to write a letter of gratitude to the members of Congress who were instrumental in securing strong funding (in the Labor/HHS appropriations bill) for HIV/AIDS-related federal programs. Thank them for their hard work, remind them how crucial this funding is to helping communities respond to the epidemic, and let them know how vital it is that they continue their leadership on this issue. Members to thank include: Senators: Arlen Specter (R-PA) and Tom Harkin (D-IA) Representatives: John Porter (R-IL), Rep. David Obey (D-WI), Nancy Pelosi (D-CA) Address your letters: The Honorable _____ U.S. Senate Washington, DC 20510 Dear Senator _____: OR The Honorable _____ U.S. House of Representatives Washington, DC 20515 Dear Representative _____: In addition, please send a thank-you note to Rep. Mark Foley (R-FL) for his tireless and successful efforts to preserve the authority of the secretary of health and human services to lift the ban on federal funding for syringe exchange programs. [If you can, please also send a copy of your letters to AIDS Action.] * * * * * FY 1998 Appropriations Levels For Federal AIDS Programs (as of November 11, 1997; increases or decreases from the FY 97 numbers are shown in parentheses) CDC Prevention FY97 Actual: $616.8m FY98 President's Budget Request 2/6/97: $634m (+17m) FY98 House Action 7/22/97: $622m (+5m)(.8%) FY98 Senate Action 9/11/97: $646.8m (+30m) (4.6%) FY98 FINAL 11/07//97***: $634.3m (+17.5m) (2.8%) HRSA -- Ryan White CARE Act Total FY97 Actual: $996.3m FY98 President's Budget Request 2/6/97: $1,036.3m (+40m) FY98 House Action 7/22/97: $1,168.3m (+172m) (17.3%) FY98 Senate Action 9/11/97: $1,077m (+81m) (7.5%) FY98 FINAL 11/07//97**: $1,150.2m (+153.9m) (15.4%) Title I FY97 Actual: $449.9m FY98 President's Budget Request 2/6/97: $454.9m (+5m) FY98 House Action 7/22/97: $471.6m (+21.7m) (4.8%) FY98 Senate Action 9/11/97: $457.9m (+8m) (1.7%) FY98 FINAL 11/07//97**: $464.8m (+14.9m) (3.3%) Title II: Care Services FY97 Actual: $250m FY98 President's Budget Request 2/6/97: $265m (+15m) FY98 House Action 7/22/97: $262m (+12m) (4.8%) FY98 Senate Action 9/11/97: $253m (+3m) (1.2%) FY98 FINAL 11/07//97**: $257.5m (+7.5m) (3%) Title II: ADAP FY97 Actual: $167m FY98 President's Budget Request 2/6/97: $167m (+0) FY98 House Action 7/22/97: $299m (+132m) (79%) FY98 Senate Action 9/11/97: $217m (+50m) (23%) FY98 FINAL 11/07//97**: $285.5m (+118.5m) (71%) Title IIIb FY97 Actual: $69.6m FY98 President's Budget Request 2/6/97: $84.6m (+15m) FY98 House Action 7/22/97: $73m (+3.4m) (4.9%) FY98 Senate Action 9/11/97: $79.5m (+10m) (12.6%) FY98 FINAL 11/07//97**: $76.3m (+6.7m) (9.6%) Title IV FY97 Actual: $36m FY98 President's Budget Request 2/6/97: $40m (+4m) FY98 House Action 7/22/97: $37.7m (+1.7m) (4.7%) FY98 Senate Action 9/11/97: $45m (+9m) (20%) FY98 FINAL 11/07//97**: $41m (+5m) (13.9%) Title V: AETCs FY97 Actual: $16.3m FY98 President's Budget Request 2/6/97: $17.3m (+1m) FY98 House Action 7/22/97: $17.1m (+.8m) (4.9%) FY98 Senate Action 9/11/97: $17.3m (+1m) (5.8%) FY98 FINAL 11/07//97**: $17.3m (+1m) (6.1%) Title V: Dental Reimbursement FY97 Actual: $7.5m FY98 President's Budget Request 2/6/97: $7.5m (+0) FY98 House Action 7/22/97: $7.9m (+.4m) (5.3%) FY98 Senate Action 9/11/97: $7.5m (+0) FY98 FINAL 11/07//97**: $7.8m (+.3m) (4%) NIH -- AIDS Research FY97 Actual: $1,501.7m FY98 President's Budget Request 2/6/97: $1,541.7m (+40m) FY98 House Action 7/22/97: $1,574.7m (+73m) (4.8%) FY98 Senate Action 9/11/97: * FY98 FINAL 11/07//97***: $1,608m**** (+106.3m) (7.1%) HUD -- HOPWA FY97 Actual: $196m FY98 President's Budget Request 2/6/97: $204m (+8m) FY98 House Action 7/22/97: $204m (+8m) (3.9%) FY98 Senate Action 9/11/97: $204m (+8m) (3.9%) FY98 FINAL 11/07//97**: $204m** (+8m) (3.9%) SAMHSA (Substance Abuse Prevention & Treatment Blockgrant) FY97 Actual: $1,360.1m FY98 President's Budget Request 2/6/97: $1,370m (+10m) FY98 House Action 7/22/97: $1,373m (+13m) (1%) FY98 Senate Action 9/11/97: $1,360.1m (+0) FY98 FINAL 11/07//97***: $1,360.1m (+0) Full House vote was completed 9/17/97. Full Senate vote was completed 9/11/97. * Total funding for NIH research was increased by 7.5% in the Senate bill, although no funding level was specified for AIDS research. ** VA/HUD programs were funded through H.R. 2158, which was signed into law on 10/27/97. HOPWA received $204 million. * Funding for prevention, the Ryan White CARE Act, research, and SAMHSA is included in the Labor/HHS conference report. The report was passed by the House and Senate (on 11/7//97 and 11/8/97, respectively) and awaits President Clinton's signature. **** This total includes $1,595 million specified for the Office of AIDS Research and $13 million specified for the development of an AIDS vaccine research facility. *